ZURCHER KANTONALBANK (ZURICH CANTONALBANK) – Vertex Pharmaceuticals Incorporated Transaction History
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) portfolio value:
$114.24M
portfolio value
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +9.26% | 33.44K shares | 12.48M | $289.54 | 394.55K |
Q2 2022 | share | Increase | +26.01% | 74.54K shares | 26.97M | $281.79 | 361.11K |
Q1 2022 | share | Increase | +126.89% | 160.26K shares | 47.04M | $260.97 | 286.56K |
Q4 2021 | share | Decrease | -13.26% | -19.30K shares | 1.32M | $222.45 | 126.30K |
Q3 2021 | share | Decrease | -2.64% | -3.95K shares | -3.74M | $181.39 | 145.60K |
Q2 2021 | share | Increase | +56.88% | 54.22K shares | 9.67M | $201.63 | 149.56K |
Q1 2021 | share | Increase | +17.79% | 14.39K shares | 1.35M | $214.89 | 95.33K |
Q4 2020 | share | Increase | +12.43% | 8.95K shares | -461K | $236.34 | 80.93K |
Q3 2020 | share | Increase | +16.92% | 10.41K shares | 1.71M | $272.12 | 71.98K |
Q2 2020 | share | Decrease | -23.78% | -19.21K shares | -1.34M | $290.31 | 61.56K |
Q1 2020 | share | Increase | +33.34% | 20.19K shares | 5.95M | $237.95 | 80.77K |
Q4 2019 | share | Increase | +14.35% | 7.60K shares | 4.28M | $218.95 | 60.57K |
Q3 2019 | share | Increase | +2.51% | 1.29K shares | -502K | $169.42 | 52.97K |
Q2 2019 | share | Decrease | -11.63% | -6.8K shares | -1.28M | $183.38 | 51.67K |
Q1 2019 | share | Increase | +19.52% | 9.55K shares | 2.64M | $183.95 | 58.47K |
Q4 2018 | share | Decrease | -60.42% | -74.70K shares | -15.72M | $165.71 | 48.92K |
Q3 2018 | share | Decrease | -3.49% | -4.47K shares | 2.05M | $192.74 | 123.62K |
Q2 2018 | share | Decrease | -2.89% | -3.81K shares | 273K | $169.96 | 128.09K |
Q1 2018 | share | Increase | +8.10% | 9.88K shares | 3.21M | $162.98 | 131.91K |
Q4 2017 | share | Increase | +30.47% | 28.49K shares | 4.06M | $149.86 | 122.02K |
Q3 2017 | share | Increase | +101.60% | 47.13K shares | 8.24M | $152.04 | 93.52K |
Q2 2017 | share | Decrease | -0.14% | -64 shares | 899K | $128.87 | 46.39K |
Q1 2017 | share | Increase | +6.07% | 2.65K shares | 1.85M | $109.35 | 46.45K |
Q4 2016 | share | Decrease | -5.71% | -2.65K shares | -824K | $73.67 | 43.79K |
Q3 2016 | share | Increase | +61.83% | 17.74K shares | 1.58M | $87.21 | 46.44K |
Q2 2016 | share | Increase | +36.01% | 7.59K shares | 791K | $86.02 | 28.70K |
Q1 2016 | share | 0.00% | 0 shares | -978K | $79.49 | 21.10K |